Redefining Access to Medicines
As part of its annual ISNTD d³ conference on drug discovery, development and diagnostics for tropical diseases, the International Society for Neglected Tropical Diseases (ISNTD) hosts a panel discussion and focus session on how to improve access to medicines for the world's poorest, exploring issues such as innovative funding mechanisms and patient & community networks to accelerate access to medicines and diagnostics.
Find out more from seven presentations and a panel discussion; the panelists are:
-
Chair: Andrew Jack (Financial Times)
-
Beatrice Greco (Merck Global Health Institute)
-
Jeffrey Moe (Duke Global Health Institute)
-
Eric Stobbaerts (DNDi)
-
Goylette Chami (University of Cambridge, Department of Pathology)
-
Danny Edwards (Access to Medicines Foundation)
-
Poppy Lamberton (University of Glasgow)
-
Margaret Olele (American Business Council)
ISNTD panel discussion: Redefining Access to Medicines
How can we improve access to medicines for the world's most vulnerable or remote patients? How can sustainable funding be secured to ensure that global healthcare needs are met, including for the world's poorest patients? How can public-private partnerships accelerate access to medicines?
Jeffrey Moe (Duke Global Health Institute)
Access and the Priority Review Voucher
Poppy Lamberton (University of Glasgow)
Low praziquantel coverage: systematic non-compliance or systematically not offered?
Dr. Beatrice Greco (Merck Global Health Institute)
The Pediatric Praziquantel Program Case Study
Margaret Olele (American Business Council)
The Labyrinth of Access to Healthcare in LMICs
Eric Stobbaerts (DNDi)
Scaling up Access to Care for Chagas Disease
Danny Edwards (Access to Medicine Foundation)
Considerations for sustainable access
Goylette Chami (University of Cambridge)
Community Drug Distribution & Access to Medicines